Cover 2 Resources
Cover 2 Resources
Ep. 227 - Landmark Racketeering Case Against Insys Therapeutics Brings Up A Familiar Story
Ep. 227 - Landmark Racketeering Case Against Insys Therapeutics Brings Up A Familiar Story
Ep. 227 - Landmark Racketeering Case Against Insys Therapeutics Brings Up A Familiar Story
Tuesday 12th February 2019
Uncover the deceptive marketing tactics of Insys Therapeutics and Purdue Pharma that fueled the opioid crisis. Listen to Cover2 Resources now.
29 minutes
Informative
Thought-provoking
Raw
Engaging
Educational
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Unmasking the Deceptive Tactics of Big Pharma: The Insys and Purdue Pharma Scandals
And I want to tell you that the patients that used this drug- and you know, and for off label purposes, for like, I don't know those are people who might have had lupus or migraines or back pain, or you know, they were rendered pretty much immobilized.
Pharmaceutical companies wield immense power, but what happens when that power is misused? This episode of Cover2 Resources dives deep into the murky waters of pharmaceutical marketing, spotlighting the infamous racketeering case against Insys Therapeutics and the notorious practices of Purdue Pharma. Host Greg McNeil sits down with investigative journalists John Pacenti and Pat Beall to unravel the web of deceit spun by these corporations.
They discuss how Insys, led by founder John Kapoor, allegedly bribed doctors to prescribe their potent fentanyl spray, SUBSYS, resulting in nearly a thousand overdose deaths between 2012 and 2016. The conversation also touches on Purdue Pharma's similar tactics, which led to their guilty plea in 2007, yet these unethical practices persist. This episode isn't just about pointing fingers; it's a call to understand the importance of addiction education and responsible pain management.
If you're keen to learn how these corporate giants have impacted the opioid crisis and what can be done to prevent future tragedies, this episode is a must-listen.